, Tracking Stock Market Picks
Enter Symbol:
Iridex Corporation (IRIX) [hlAlert]

up 646.66 %

Iridex Corporation (IRIX) rated Buy by Maxim Group

Posted on: Tuesday,  Dec 23, 2008  10:25 AM ET by Maxim Group

Maxim Group rated Buy Iridex Corporation (NASDAQ: IRIX) on 12/23/2008, when the stock price was $0.90. Since
then, Iridex Corporation has gained 646.67% as of 01/26/2016's recent price of $6.72.
If you would have followed this Maxim Group's recommendation on IRIX, you would have gained 646.66% of your investment in 2590 days.

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/23/2008 10:25 AM Buy
as of 12/24/2008
1 Week up  63.52 %
1 Month   
3 Months   
1 YTD up  63.52 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy